
Results
12
Companies which are potentially undervalued and in an acceptable financial position.
12 companies
Otsuka Holdings
Market Cap: JP¥5.4t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥10,230.00
7D
-3.0%
1Y
41.8%
Kissei Pharmaceutical
Market Cap: JP¥161.9b
Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.
4547
JP¥3,950.00
7D
3.4%
1Y
-6.0%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,787.00
7D
-2.0%
1Y
11.1%
Sumitomo Pharma
Market Cap: JP¥616.6b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,418.50
7D
-6.3%
1Y
35.5%
Astellas Pharma
Market Cap: JP¥3.8t
Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.
4503
JP¥2,152.50
7D
0.2%
1Y
55.4%
Santen Pharmaceutical
Market Cap: JP¥618.7b
Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.
4536
JP¥1,902.50
7D
-2.6%
1Y
13.8%
Ono Pharmaceutical
Market Cap: JP¥1.0t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,265.00
7D
0.8%
1Y
45.1%
Daiichi Sankyo Company
Market Cap: JP¥4.6t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥2,546.00
7D
0.7%
1Y
-27.2%
Chugai Pharmaceutical
Market Cap: JP¥12.3t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,428.00
7D
-0.5%
1Y
-0.5%
Kyowa Kirin
Market Cap: JP¥1.3t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,388.50
7D
1.1%
1Y
-4.3%
Tsumura
Market Cap: JP¥277.6b
Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.
4540
JP¥3,723.00
7D
0.2%
1Y
10.3%
PeptiDream
Market Cap: JP¥120.5b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥925.10
7D
-9.0%
1Y
-44.3%